Polyamines are essential for the growth and proliferation of mammalian cells and are
intimately involved in biological mechanisms such as DNA replication, RNA transcription …

Gastric cancer (GC) is the fourth leading cause of death worldwide, with more than 1 million
cases diagnosed every year. Helicobacter pylori represents the main risk factor, being …

BACKGROUND Gastric cancer (GC) is the sixth most common cancer and third leading
cause of cancer-related deaths worldwide. Current treatments mainly rely on surgery-and …

Combined chemotherapy and targeted therapy holds immense potential in the management
of advanced gastric cancer (GC). GC tissues exhibit an elevated expression level of protein …

Recent years have witnessed a significant convergence of artificial intelligence (AI) within
the healthcare sector. This chapter explores the transformative potential and challenges …

Conspectus Pathogen infection can lead to deterioration of physical fitness, organ function
decline, and even death, and the continuous interhuman transmissions contribute to the …

Background We report the final results of the randomized phase 2 FIGHT trial that evaluated
bemarituzumab, a humanized monoclonal antibody selective for fibroblast growth factor …

Gastric cancer is one of the most prevalent cancer types worldwide, and its resistance to
cancer therapies, such as chemotherapy and radiotherapy, has made treating it a major …

Gastric cancer (GC) remains a significant contributor to cancer-related mortality. Novel high-
throughput techniques have enlightened the epigenetic mechanisms governing gene …

Gastric cancer (GC) is a heterogeneous disease, often diagnosed at advanced stages, with
a 5-year survival rate of approximately 20%. Despite notable technological advancements in …